What is the recommended duration of treatment with Diamox (acetazolamide) for an adult patient at risk of or experiencing altitude sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Diamox (Acetazolamide) Treatment for Altitude Sickness

For altitude sickness prevention, acetazolamide should be started 1-3 days before ascent and continued for 2-3 days after reaching your target altitude, then discontinued.

Prophylactic Dosing Timeline

Pre-Ascent Initiation

  • Start acetazolamide the night before or 1-3 days prior to ascent at a dose of 125 mg twice daily or 250 mg twice daily 1, 2, 3
  • Starting the night before ascent is the traditional approach and shows slightly better efficacy than same-day dosing, though day-of-ascent dosing may be acceptable for convenience 4
  • The 3-day pre-treatment period has been validated in high-risk rapid ascent scenarios 3

Duration at Altitude

  • Continue acetazolamide for 2-3 days after arrival at your terminal (highest) altitude 1, 2
  • This allows adequate time for physiological acclimatization to occur 2
  • For staged ascents with multiple altitude gains, continue throughout the ascent period plus 2-3 days at final altitude 1

Total Treatment Duration

  • Typical total duration: 3-6 days (1-3 days pre-ascent + 2-3 days at altitude) 2, 3
  • Dexamethasone, if used as an alternative, should never be used for more than 2-3 days due to side effect concerns 2

Special Circumstances

High-Altitude Pulmonary Edema (HAPE) Prevention

  • For patients with prior HAPE history, nifedipine should be started with ascent and continued for 3-4 days after arrival at terminal altitude 1
  • This is a longer duration than standard AMS prophylaxis due to the life-threatening nature of HAPE 1

Cardiovascular Patients

  • Patients with pre-existing cardiovascular conditions should continue their regular medications throughout altitude exposure 5, 1
  • Acetazolamide can be added for AMS prevention using the same 2-3 day post-arrival duration, but requires careful monitoring when combined with other diuretics due to dehydration and electrolyte imbalance risks 5
  • The European Society of Cardiology notes acetazolamide may reduce subendocardial ischemia risk at high altitude 5, 1

Optimal Dosing

Standard Dose

  • 125 mg twice daily is the recommended dose with the best balance of efficacy and tolerability 1, 6, 7
  • Alternative: 250 mg twice daily or 500 mg once daily (slow-release formulation) 1, 2

Lower Doses Not Recommended

  • Acetazolamide 62.5 mg twice daily is inadequate and increases AMS risk (number needed to harm = 9) compared to 125 mg twice daily (number needed to treat = 4.8) 6
  • Doses below 125 mg twice daily should not be used despite speculation about reduced side effects 6, 7

Common Pitfalls

Premature Discontinuation

  • Do not stop acetazolamide immediately upon reaching altitude - the 2-3 day continuation period is critical for acclimatization 2
  • Stopping too early negates the prophylactic benefit 2

Excessive Duration

  • Prolonged use beyond 2-3 days at terminal altitude is unnecessary for standard AMS prevention 2
  • Extended use increases cumulative side effects (paresthesias, altered taste, polyuria) without additional benefit 5, 7

Inadequate Pre-Treatment

  • Starting acetazolamide only on the day of ascent shows marginally higher AMS rates (48% vs 39%) compared to night-before dosing 4
  • While day-of dosing may be acceptable for convenience, night-before or 1-3 day pre-treatment is superior 4, 3

Side Effect Considerations

  • Common adverse effects include paresthesias, vertigo, and unpleasant taste, which are generally mild but dose-related 5, 7
  • These effects typically resolve upon discontinuation after the 2-3 day altitude exposure period 7
  • The 125 mg twice daily dose provides similar efficacy to higher doses with a more favorable side-effect profile 7

References

Guideline

Prophylaxis of Altitude Sickness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Medicine and mechanisms in altitude sickness. Recommendations.

Sports medicine (Auckland, N.Z.), 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the proper dosing and use of acetazolamide (Carbonic Anhydrase Inhibitor) for the prevention and treatment of Acute Mountain Sickness (AMS)?
What is the recommended dosing strategy for acetazolamide (carbonic anhydrase inhibitor) to prevent acute mountain sickness (AMS) in a patient ascending to altitudes of 7,000-11,000 feet for 12 days with variable ascents and descents?
What is the recommended medication and dosage for preventing altitude sickness?
What medication is used to treat altitude sickness (Acute Mountain Sickness)?
What is the recommended treatment and prevention for altitude sickness?
What are the best treatment options for a young child with constipation and fecal impaction resistant to Miralax (polyethylene glycol) and accompanied by vomiting?
What is the recommended treatment for a patient with viral conjunctivitis (viral pink eye)?
What is the best approach to manage migraines in a patient with Postural Orthostatic Tachycardia Syndrome (POTS)?
What are the symptoms and treatment options for pulmonary hypertension, particularly in patients with a history of heart disease, lung disease, or connective tissue disorders?
What is the diagnosis and recommended treatment for a adult patient with 2-day history of black diarrhea and generalized abdominal pain, who has shown improvement with Imodium (loperamide)?
Which of the following medications is most likely to produce hyponatremia: oxybutynin, dapagliflozin, spironolactone, pioglitazone (Actos), losartan, metoprolol, or metformin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.